- Pyrazinamide 1.25g/5ml oral suspension
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Pyrazinamide 1.25g/5ml oral suspension | Start Date 06-02-2008 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- J04AK01
- BNF Codes
-
- BNF code 05010900
Code | Start Date | End Date |
---|---|---|
13201211000001104 | 06-02-2008 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Pyrazinamide | Based on Ingredient Substance | 250 mg | 1 ml |
Name
Pyrazinamide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
250
Strength and UOM (Dmr)
1
Parent Products
-
VTMPyrazinamide
-
VMP(Current) Pyrazinamide 1.25g/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 ml |